Skip to main content
Skip to footer
Firm
Our team
Join us
Expertise
Expertise
Patents
UPC
FRAND and SEPs
Pharma and SPCs
Trade secrets
Saisie-contrefaçon
Contracts
Patent valuation
Employee inventions
All fields of expertise
Services
Patent litigation
Bringing an infringement action
Infringement defence
Invalidity action
Provisional measures
Evidence before the UPC
The FRAND undertaking
Arbitration and mediation
Advice:
Second opinion
Litigation readiness
Saisie-contrefaçon preparedness
Trade secret audit
IP due diligence
Local counsel in France
Japan and Europe
Defensible portfolio
Litigation funding
All services
Technologies
Technical fields
Electronics
Telecoms and FRAND
Pharmaceuticals
Medical devices
Chemistry
Biotechnology
Mechanical engineering
Publications
Blog
Kluwer Patent Blog
Journals and books
Speaking engagements
Patent litigation news
Consultation responses
Glossary
All publications
Le Lab
UPC Litigation Watch
UPC decisions analysed
UPC statistics
FRAND Litigation Watch
FRAND decisions analysed
Pharma Litigation Watch
Pharma decisions analysed
Subscribe to the watch
Contact
fr
en
ja
Back to blog
Category: Case Law
11 October 2026
An opt-out is not a register entry: ownership and procedural choice before the UPC
11 October 2026
An opt-out is not a register entry: ownership and procedural choice before the UPC
Patents
Litigation
UPC
Case law
7 October 2026
Patent assignment not entered in the register: the lesson of the Sony ruling
Patents
Litigation
Case law
Saisie-contrefaçon
6 October 2026
Plausibility and the right of priority: the French court faces apixaban
Patents
Litigation
Case law
Pharmaceuticals
5 October 2026
Preliminary injunctions and patent applications: the French fault line
Application for a preliminary injunction
Patents
Litigation
Case law
Pharmaceuticals
4 October 2026
Dosage inventions and inventive step: the strict reading of the French court
Patents
Litigation
Case law
Pharmaceuticals
25 September 2026
Unitary and National Patents: A Quest for Coherence
Patents
UPC
Case law
16 September 2026
G 1/25: the description as a tool for interpreting the claims
Patents
Litigation
UPC
Case law
15 September 2026
Pay-for-delay: the CJEU confirms Teva/Cephalon and defines the limits of patent settlement agreements
Patents
Litigation
Contract
Case law
Pharmaceuticals
14 September 2026
Valeo v. Bosch: the allocation of cases within the UPC, an alternative and not an exception
Patents
Litigation
Forum shopping
UPC
Case law
10 September 2026
The launch letter before the UPC: preventing urgency for generics and biosimilars
Application for a preliminary injunction
Patents
UPC
Case law
Pharmaceuticals